The review of questionnaires and scales evaluating patients with amyotrophic lateral sclerosis
Authors:
Radka Bužgová; Radka Kozáková; Renáta Zeleníková; Lucie Sikorová
Authors‘ workplace:
Ústav ošetřovatelství a porodní asistence, Lékařská fakulta Ostravské univerzity
Published in:
Čas. Lék. čes. 2018; 157: 41-45
Category:
Review Article
Overview
In patients with amyotrophic lateral sclerosis (ALS), it is advisable to provide multidisciplinary care, due to rapid progression and specific disease symptoms, in order to maintain the best quality of life for the patient and their family. Abroad, questionnaires and scales are used to assess the patient´s health condition, to determine disease progression, followed by the provision of personalized care. The aim of this review article is to describe and analyze the scales used in evaluating ALS patients in both functional and psychosocial areas.
Having searched in electronic databases, 14 scales for patients with ALS or motor neuron disease were found, and 4 scales for patients with chronic diseases, which are appropriate and used also in patients with ALS. The ALSFRS scale (The Amyotrophic Lateral Sclerosis Functional Rating Scale) is most often used for assessment of functional status. All areas of care are best covered in the ALSSQOL-R (Amyotrophic Lateral Sclerosis Specific Quality of life) questionnaire, designed for assessment of quality of life. The use of both scales is recommended in clinical practice and research.
Keywords:
amyotrophic lateral sclerosis, questionnaires, quality of life, multidisciplinary care, scales
Sources
1. Ambler Z. Onemocnění motorického neuronu. In: Bednařík J. (ed.). Klinická neurologie II. Triton, 2010.
2. Ridzoň P, Mazanec R. Paliativní péče u terminálních stavů chorob motorického neuron (amyotrofické laterální sklerózy, progresivní bulbární paralýzy a progresivní svalové atrofie). Paliativní medicína a léčba bolesti 2011; 4(1): 8–10.
3. Švancara J, Sláma O, Kabelka L et al. Národní datová základna paliativní péče. Ústav zdravotnických informací ČR. Dostupné na: www.paliativnidata.cz
4. Sláma O, Špinková M, Kabelka L. Standardy paliativní péče. Česká společnost paliativní medicíny ČLS JEP, 2013.
5. Galvin M, Madden C, Maquire S et al. Patient journey to a specialist amyotrophic lateral sclerosis multidisciplinary clinic: an exploratory study. BMC Health Serv Res 2015; 15: 1–8.
6. Luo LL. The use of International Classification of Functioning, Disability and Health in motor neurone disease rehabilitation. The University of Melbourne, 2011.
7. Norris FH Jr, Calanchini PR, Fallat RJ et al. The administration of guanidine in amyotrophic lateral sclerosis. Neurology 1974; 24(8): 721–728.
8. Appel V, Stewart SS, Smith G et al. A rating scale for amyotrophic lateral sclerosis: description and preliminary experience. Ann Neurol 1987; 22(3): 328–333.
9. Cedarbaum JM, Stambler N. Performance of the ALS Functional Rating Scale (ALSFRS) in multicenter clinical trials. J Neurol Sci 1997; 152(Suppl.): 1–9.
10. Cedarbaum JM, Stambler N, Malta E et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci 1999; 169: 13–21.
11. Hillel AD, Miller RM,Xorkston K et al. Amyotrophic lateral sclerosis severity scale. Neuroepidemiology 1989; 8(3): 142–150.
12. Jenkinson C, Levvy G, Fitzpatrick R et al. The amyotrophic lateral sclerosis assessment questionnaire (ALSAQ-40): tests of data quality, score reliability and response rate in a survey of patients. J Neurol Sci 2000; 180(1–2): 94–100.
13. Jenkinson C, Fitzpatrick R. Reduced item set for the amyotrophic lateral sclerosis assessment questionnaire: development and validation of the ALSAQ-5. J Neurol Neurosurg Psychiatry 2001; 70(1): 70–73.
14. McGuire D, Garrison L, Armon C et al. A brief quality of life measure for ALS clinical trials based on a subset of items from the sickness impact profile. The Syntex-Synergen ALS/CNTF Study Group. J Neurol Sci 1997; 152(Suppl. 1): S18.
15. Sen AK. Inequality reexamined. Oxford University Press, New York, 1992.
16. Simmons Z, Felgoise SH, Rodriguez JL et al. Validation of a shorter ALS specific quality of life instrument: the ALSQOL-R. Neurology 2010; 74(Suppl. 2): A177–A178.
17. Felgoise SH, Walsh SM, Stephens HE et al. The ALS Specific Quality of Life-Revised (ALSSQOL-R) User’s Guide, 2011. Dostupné na: www.pennstatehershey.org/c/document_library/get_file?uuid=b9de0a6a-9c1d-4f77-bdf0-5c6c846e018e&groupId=22147
18. Franceschini AC, Mourao LF. Dysarthria and dysphagia in amyotrophic lateral sclerosis with spinal onset: a study of quality of life related to swallowing. NeuroRehabilitation 2015; 36(1): 127–134.
19. Londral A, Pinto A, Pinto S et al. Quality of life in amyotrophic lateral sclerosis patients and caregivers: impact of assistive communication from early stages. Muscle Nerve 2015; 52(6): 933–941.
20. Raaphorst J, Beeldman E, Schmand B et al. The ALS-FTD-Q: a new screening tool for behavioural disturbances in ALS. Neurology 2012; 79: 1377–1383.
21. Lee JN, Rigby SA, Burchardt F et al. Quality of life issues in motor neurone disease: the development and validation of a coping strategies questionnaire, the MND Coping Scale. J Neurol Sci 2001; 191: 79–85.
22. Montel S, Albertini L, Desnuelle C et al. The impact of active coping strategies on survival in ALS: the first pilot study. Amyotroph Lateral Scler 2012; 13(6): 599–601.
23. Hammer EM, Hacker S, Hautzinger M et al. Validity of the ALS-Depression-Inventory (ADI-12) – a new screening instrument for depressive disorders in patients with amyotrophic lateral sclerosis. J Affect Disord 2008; 109(1–2): 213–219.
24. Turner-Stokes L. The Needs and Provision Complexity Scale (NPCS) for LTNX. King’s College, London, 2008.
25. Cardol M, de Haan RJ, van den Bos GA et al. The development of a handicap assessment questionnaire: the Impact on Participation and Autonomy (IPA). Clinic Rehab 1999; 13: 411–419.
26. Lomas J, Pickard L, Bester S et al. The communicative effectiveness index: development and psychometric evaluation of a functional communication measure for adult aphasia. J Speech Hear Disord 1989; 54(1): 113–124.
Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistArticle was published in
Journal of Czech Physicians
Most read in this issue
- Palliative care for patients at home
- Palliative care in nephrology
- The review of questionnaires and scales evaluating patients with amyotrophic lateral sclerosis
- Geriatric palliative care